Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt’s hepatocellular cancer epidemic: simulation of alternatives
Crossref DOI link: https://doi.org/10.1136/bmjgh-2017-000572
Published Online: 2018-04-20
Published Print: 2018-04
Update policy: https://doi.org/10.1136/crossmarkpolicy
Ma, Wenkang
Soliman, Amr S
Anwar, Wagida A
Hablas, Ahmed
El Din, Tamer B
Ramadan, Mohamed
Seifeldin, Ibrahim A
Wilson, Mark L
Funding for this research was provided by:
National Cancer Institute, National Institutes of Health
Office of Global Health, University of Michigan
